PLAGL2 Monoclonal antibody, PBS Only

PLAGL2 Monoclonal Antibody for WB, Indirect ELISA

Host / Isotype

Mouse / IgG1

Reactivity

Human, rabbit

Applications

WB, Indirect ELISA

Conjugate

Unconjugated

CloneNo.

3C2E5

Cat no : 68606-1-PBS

Synonyms

FLJ23283, KIAA0198, PLAGL2, Zinc finger protein PLAGL2

---

Validation Data Gallery

• 

  WB analysis using 68606-1-Ig (same clone as 68606-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 68606-1-Ig (PLAGL2 antibody) at dilution of 1:5000 incubated at room temperature for 1.5 hours. The membrane was stripped and reblotted with HRP-conjugated GAPDH Monoclonal antibody (HRP-60004) as loading control. This data was developed using the same antibody clone with 68606-1-PBS in a different storage buffer formulation.

• 

  WB analysis of rabbit testis using 68606-1-Ig (same clone as 68606-1-PBS)

  rabbit testis tissue were subjected to SDS PAGE followed by western blot with 68606-1-Ig (PLAGL2 antibody) at dilution of 1:5000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 68606-1-PBS in a different storage buffer formulation.

---

Product Information

68606-1-PBS targets PLAGL2 in WB, Indirect ELISA applications and shows reactivity with Human, rabbit samples.

• Tested Reactivity: Human, rabbit
• Host / Isotype: Mouse / IgG1
• Class: Monoclonal
• Type: Antibody
• Immunogen: PLAGL2 fusion protein Ag30227
• Full Name: pleiomorphic adenoma gene-like 2
• Calculated Molecular Weight: 496 aa, 55 kDa
• Observed Molecular Weight: 50-55 kDa
• GenBank Accession Number: BC023655
• Gene Symbol: PLAGL2
• Gene ID (NCBI): 5326
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Protein G purification
• Storage Buffer: PBS Only
• Storage Conditions: Store at -80°C.

Background Information

PLAGL2, also named KIAA0198, belongs to the krueppel C2H2-type zinc-finger protein family. It shows weak transcriptional activatory activity. PLAGL2, a proto-oncogene, is implicated in a variety of cancers including acute myeloid leukemia (AML), malignant glioma, colon cancer, and lung adenocarcinoma. PLAGL2 can function as a tumor suppressor by initiating cell cycle arrest and apoptosis. The calculated molecular weight of PLAGL2 is 55 kDa, but the SUMO1-modifIed form is 68 kDa (PMID: 30535429).